Nova Leap Health Résultats passés
Passé contrôle des critères 2/6
Nova Leap Health's earnings have been declining at an average annual rate of -8.3%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 12.3% per year. Nova Leap Health's return on equity is 0.7%, and it has net margins of 0.5%.
Informations clés
-8.3%
Taux de croissance des bénéfices
-3.4%
Taux de croissance du BPA
Healthcare Croissance de l'industrie | 8.5% |
Taux de croissance des recettes | 12.3% |
Rendement des fonds propres | 0.7% |
Marge nette | 0.5% |
Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
Ventilation des recettes et des dépenses
Comment Nova Leap Health gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 26 | 0 | 8 | 0 |
31 Mar 24 | 26 | 0 | 8 | 0 |
31 Dec 23 | 26 | -1 | 8 | 0 |
30 Sep 23 | 26 | -1 | 9 | 0 |
30 Jun 23 | 27 | -1 | 9 | 0 |
31 Mar 23 | 27 | -1 | 9 | 0 |
31 Dec 22 | 28 | -1 | 10 | 0 |
30 Sep 22 | 27 | -1 | 9 | 0 |
30 Jun 22 | 25 | 0 | 9 | 0 |
31 Mar 22 | 24 | 0 | 8 | 0 |
31 Dec 21 | 21 | 2 | 8 | 0 |
30 Sep 21 | 20 | 4 | 7 | 0 |
30 Jun 21 | 19 | 3 | 7 | 0 |
31 Mar 21 | 18 | 2 | 6 | 0 |
31 Dec 20 | 17 | 1 | 6 | 0 |
30 Sep 20 | 18 | 0 | 6 | 0 |
30 Jun 20 | 18 | -1 | 5 | 0 |
31 Mar 20 | 18 | 0 | 5 | 0 |
31 Dec 19 | 17 | -1 | 5 | 0 |
30 Sep 19 | 16 | -1 | 5 | 0 |
30 Jun 19 | 15 | -1 | 5 | 0 |
31 Mar 19 | 13 | -1 | 4 | 0 |
31 Dec 18 | 10 | -1 | 4 | 0 |
30 Sep 18 | 7 | -1 | 3 | 0 |
30 Jun 18 | 5 | -1 | 2 | 0 |
31 Mar 18 | 2 | -1 | 2 | 0 |
31 Dec 17 | 1 | -1 | 1 | 0 |
31 Dec 16 | 0 | 0 | 0 | 0 |
31 Oct 16 | 0 | 0 | 0 | 0 |
Des revenus de qualité: NVLP.F has a large one-off loss of $1.2M impacting its last 12 months of financial results to 30th June, 2024.
Augmentation de la marge bénéficiaire: NVLP.F became profitable in the past.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: NVLP.F has become profitable over the past 5 years, growing earnings by -8.3% per year.
Accélération de la croissance: NVLP.F has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Bénéfices par rapport au secteur d'activité: NVLP.F has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).
Rendement des fonds propres
ROE élevé: NVLP.F's Return on Equity (0.7%) is considered low.